Micro bio of today's guest:
Chris McCullough is the co-founder and CEO of Rotageek, a SaaS platform for data-driven scheduling of rotas for frontline staff.
Prior to becoming a tech entrepreneur, Chris was formerly an A&E Doctor. – and thus he is in an enviable position to separate facts from fiction as well as government spin with regards to COVID-19.
What you will learn in this episode:
Because of his professional insights, we first talk about the virus itself in some length, his view of how various countries responded to the pandemic and his expectation of a second spike in transmission in the UK. This is a 100% no-nonsense, fact-based, un-biased and non-politicised account of a medical expert (Chris refers to himself as an amateur – I'll let you decide for yourself!) on COVID-19 – with zero agenda, something that is hard to come by these days.
In the second half we learn how Rotageek is making lives for hospital managers and clinical staff better – and why his company is offering their software as a service for free to the NHS at the moment.
What I admire most in Chris are his strong moral principles, and I bet that at the end of this interview – or therapy session as he refers to it at the end – you will agree with me that Chris is not only one of the most humble and value-driven Tech CEOs, but also a role model for a social capitalist in the 21stcentury – one who marries purpose and principles with making a profit and who embodies that with everything he says and does.
The likes of Chris are part of a global movement of conscious capitalists, whether they see themselves as such or 'just do it'. Below is an interesting article on the subject matter by Gretchen Fox.
Useful links:
https://www.forbes.com/sites/gretchenfox/2019/03/26/the-rise-of-conscious-capitalism/#49466aa7139d
https://www.rotageek.com
https://www.calculuscapital.com – the lead investor for Rotageek's latest financing round
https://www.mobeus.co.uk – Rotageek's previous investor
https://www.linkedin.com/in/ctmccullough – connect with Chris on LinkedIn
